Poly-2-methyl-2-oxazoline–modified bioprosthetic heart valve leaflets have enhanced biocompatibility and resist structural degeneration
Open Access
- 7 February 2022
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 119 (6)
Abstract
Significance: Heart valve disease affects millions, and since there is no effective medical therapy, surgical repair when possible—or more commonly, replacement—are the only treatments available. Bioprosthetic heart valves (BHV), the most frequently used valve replacements, are composed of heterograft tissue, typically fixed in glutaraldehyde, and prepared for human use either as surgically implantable devices or for transcatheter delivery. Protein-glycation limits the durability of BHV, contributing to device failure, often requiring reoperation after only a decade or less of functionality. This problem is addressed by modifying BHV leaflets with poly-2-methyl-2-oxazoline, effectively mitigating glycation and serum protein infiltration and enhancing biocompatibility.Keywords
Funding Information
- HHS | National Institutes of Health (HL143008)
- HHS | National Institutes of Health (HL007915)
This publication has 48 references indexed in Scilit:
- Triglycidyl Amine Crosslinking Combined With Ethanol Inhibits Bioprosthetic Heart Valve CalcificationThe Annals of Thoracic Surgery, 2011
- Polyoxazoline: Chemistry, Properties, and Applications in Drug DeliveryBioconjugate Chemistry, 2011
- Bioprosthetic heart valves: modes of failureHistopathology, 2009
- Prosthetic Heart ValvesCirculation, 2009
- Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patientsCancer, 2007
- Kinetic studies of glutaraldehyde binding in liverBiotechnic & Histochemistry, 2002
- Novel anti-calcification treatment of biological tissues by grafting of sulphonated poly(ethylene oxide)Biomaterials, 1997
- N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue ProteinsBiochemistry, 1995
- Pathology of Substitute Heart Valves: New Concepts and DevelopmentsJournal of Cardiac Surgery, 1994
- Surface passivation by human albumin of plasmaperesis circuits reduces platelet accumulation and thrombus formation. Experimental and clinical studiesJournal of Biomedical Materials Research, 1990